CORT

#1373
Corcept Therapeutics Inc.
43.1750 USD
-0.29%
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
43.0900
43.3800
Intervallo Annuale
28.6601
89.0000
Variazione giornaliera
-0.29%
Variazione Mensile
+33.42%
Variazione di 6 mesi
-41.15%
Variazione Annuale
-41.15%
Chiusura Precedente
43.3000
Apertura
43.3600
Bid
Ask
Minimo
43.0900
High
43.3800
Volume
41
Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche
Trimestrale Annuale
  • Market Capitalization 4.5927 B
  • Employee 730
  • Founded 1998
  • CEO N/A
  • Website www.corcept.com
  • Headquarter Delaware, United States
  • FIGI BBG000BKJG33
  • Industry Technology
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
42.44
Rapporto prezzo/fatturato
5.48

Corcept Therapeutics Incorporated

Corcept Therapeutics Inc. is a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders. Corcept has focused on the adverse effects of excess cortisol, studying new compounds that may mitigate those effects. Its executive team is headed by CEO, president and director Joseph K. Belanoff, MD.

Notizie